CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.590
-0.030 (-1.85%)
Dec 17, 2025, 12:10 PM EST - Market open
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $18.35 million as of December 17, 2025. Its market cap has decreased by -31.17% in one year.
Market Cap
18.35M
Enterprise Value
16.84M
1-Year Change
-31.17%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $18.35M, a decrease of -60.21%. That is a compound annual growth rate of -29.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 18.69M | -52.35% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |